ZA200108013B - Monthly closes for treatment of Streptococcus pneumoniae infections. - Google Patents

Monthly closes for treatment of Streptococcus pneumoniae infections.

Info

Publication number
ZA200108013B
ZA200108013B ZA200108013A ZA200108013A ZA200108013B ZA 200108013 B ZA200108013 B ZA 200108013B ZA 200108013 A ZA200108013 A ZA 200108013A ZA 200108013 A ZA200108013 A ZA 200108013A ZA 200108013 B ZA200108013 B ZA 200108013B
Authority
ZA
South Africa
Prior art keywords
monthly
closes
treatment
streptococcus pneumoniae
pneumoniae infections
Prior art date
Application number
ZA200108013A
Other languages
English (en)
Inventor
Thomas Reeves Parr
Margaret Mary Wasilewski
Michael Lee Zeckel
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of ZA200108013B publication Critical patent/ZA200108013B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Otolaryngology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ZA200108013A 1999-05-03 2001-09-28 Monthly closes for treatment of Streptococcus pneumoniae infections. ZA200108013B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13225899P 1999-05-03 1999-05-03

Publications (1)

Publication Number Publication Date
ZA200108013B true ZA200108013B (en) 2003-03-26

Family

ID=22453188

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200108013A ZA200108013B (en) 1999-05-03 2001-09-28 Monthly closes for treatment of Streptococcus pneumoniae infections.

Country Status (29)

Country Link
EP (1) EP1175222B1 (no)
JP (1) JP2002543146A (no)
KR (1) KR100757165B1 (no)
CN (1) CN1349407A (no)
AR (1) AR023827A1 (no)
AT (1) ATE284702T1 (no)
AU (1) AU774647B2 (no)
BR (1) BR0010244A (no)
CA (1) CA2372790A1 (no)
CZ (1) CZ296127B6 (no)
DE (1) DE60016734T2 (no)
DZ (1) DZ3039A1 (no)
EA (1) EA004295B1 (no)
HK (1) HK1044707B (no)
HR (1) HRP20010808A2 (no)
HU (1) HUP0200940A3 (no)
IL (2) IL145582A0 (no)
MY (1) MY123542A (no)
NO (1) NO20015291L (no)
NZ (1) NZ514467A (no)
PE (1) PE20010292A1 (no)
PL (1) PL353444A1 (no)
SK (1) SK285970B6 (no)
SV (1) SV2002000065A (no)
TR (1) TR200103211T2 (no)
TW (1) TWI255716B (no)
UA (1) UA73937C2 (no)
WO (1) WO2000066144A2 (no)
ZA (1) ZA200108013B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2013202360B2 (en) * 2008-08-30 2016-03-24 Melinta Therapeutics, Inc. Methods of treatment using single doses of oritavancin
US8420592B2 (en) * 2008-08-30 2013-04-16 The Medicines Company Methods of treatment using single doses of oritavancin
EP2969004A4 (en) 2013-03-15 2016-09-21 Melinta Therapeutics Inc METHOD FOR THE TREATMENT OF INFECTIONS IN OVERWEIGHT AND ADIPOSIVE PATIENTS USING ANTIBIOTICS
US20160206688A1 (en) * 2013-08-26 2016-07-21 The Medicines Company Methods for treating bacteremia and osteomyelitis using oritavancin

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840684A (en) * 1994-01-28 1998-11-24 Eli Lilly And Company Glycopeptide antibiotic derivatives

Also Published As

Publication number Publication date
JP2002543146A (ja) 2002-12-17
WO2000066144A3 (en) 2001-04-12
AR023827A1 (es) 2002-09-04
AU4329200A (en) 2000-11-17
CA2372790A1 (en) 2000-11-09
NO20015291L (no) 2001-12-17
HK1044707A1 (en) 2002-11-01
CZ296127B6 (cs) 2006-01-11
BR0010244A (pt) 2002-01-08
TR200103211T2 (tr) 2002-02-21
DE60016734D1 (de) 2005-01-20
PE20010292A1 (es) 2001-03-07
UA73937C2 (en) 2005-10-17
EA004295B1 (ru) 2004-02-26
MY123542A (en) 2006-05-31
IL145582A (en) 2008-12-29
HUP0200940A2 (en) 2002-08-28
EP1175222A2 (en) 2002-01-30
DZ3039A1 (fr) 2004-03-27
EP1175222B1 (en) 2004-12-15
KR20020008173A (ko) 2002-01-29
WO2000066144A2 (en) 2000-11-09
KR100757165B1 (ko) 2007-09-07
SK15572001A3 (sk) 2003-05-02
PL353444A1 (en) 2003-11-17
HK1044707B (zh) 2005-09-30
NO20015291D0 (no) 2001-10-29
IL145582A0 (en) 2002-06-30
CN1349407A (zh) 2002-05-15
HUP0200940A3 (en) 2002-10-28
AU774647B2 (en) 2004-07-01
NZ514467A (en) 2005-01-28
SK285970B6 (sk) 2007-12-06
SV2002000065A (es) 2002-12-02
HRP20010808A2 (en) 2002-12-31
EA200101171A1 (ru) 2002-04-25
ATE284702T1 (de) 2005-01-15
CZ20013949A3 (cs) 2002-07-17
TWI255716B (en) 2006-06-01
DE60016734T2 (de) 2005-12-08

Similar Documents

Publication Publication Date Title
ZA200202306B (en) Topical treatment of streptococcal infections.
HK1043728A1 (en) Vaccine against streptococcus pneumoniae
ZA973105B (en) Compounds and methods for the selective treatment of cancer and bacterial infections.
GB0107658D0 (en) Streptococcus pneumoniae
AU2020501A (en) Chemotherapy treatment
GB9914071D0 (en) Vehicle reversing aid
MXPA03003168A (es) Composicion antibiotica topica para el tratamiento de infeccion de los ojos.
GB0125222D0 (en) Composition for the treatment of microbial infections
ZA991273B (en) Amidinophenyl derivatives.
AU7038101A (en) Streptococcus antigens
IL162383A0 (en) Streptococcus pneumoniae vaccine
ZA200108215B (en) Compositions and methods for treatment of staphylococcal infection.
ZA200103289B (en) Novel macrolide antibiotics.
AU2247701A (en) Gram-positive selective antibacterial compounds, compositions containing such compounds and methods of treatment
ZA200108013B (en) Monthly closes for treatment of Streptococcus pneumoniae infections.
AU1212501A (en) Gram-positive selective antibacterial compounds, compositions containing such compounds and methods of treatment
DE60023158D1 (en) Phagenresistentes streptococcus thermophilus
ZA991410B (en) Compounds and methods for the treatment of bacterial dysentry using antibiotics and toxin binding oligosaccharide compositions.
GB9928678D0 (en) Streptococcus pneumoniae antigens
AU5493500A (en) Antibody-based treatment for streptococcus pneumoniae infection
AU2002336752A1 (en) Composition for treating streptococcus pneumoniae
GB9914489D0 (en) Transistors
AU1212201A (en) Gram-positive selective antibacterial compounds, compositions containing such compounds and methods of treatment
AU2001258675A1 (en) Treating infections
NO991827D0 (no) FremgangsmÕte for behandling av Streptococcus pneumoniae infeksjon